The objectives of the STREXIT 2 Project in the words of Principal Investigator and Co-Leader Dr Winan van Houdt
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part...
STREXIT 2 is part of a series of clinical trials funded by the Horizon Europe programme as part...
Over the last couple of months, we introduced the people and organisations behind the STREXIT2 Project on our...
On Sarcoma Awareness Month, the European Organisation for Research and Treatment of Cancer (EORTC) and the Syreon Research Institute are...
© The STREXIT2 Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101103843). Views and opinions expressed are however those of the authors only and do not necessarily
reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
Copyright © 2024 All rights reserved.
